112 related articles for article (PubMed ID: 9092255)
1. [A case of the immediate efficacy of chemotherapy in a female patient with a glioblastoma].
Kobiakov GL; Loshakov VA; Lichinitser MR
Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):39-41. PubMed ID: 9092255
[No Abstract] [Full Text] [Related]
2. PCV chemotherapy for recurrent glioblastoma.
Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival?
Loeffler JS; Shrieve DC; Coleman CN
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):531-3. PubMed ID: 7673044
[No Abstract] [Full Text] [Related]
5. Comparative efficacy of bevacizumab and PCV chemotherapy in recurrent glioblastoma.
Dixit S; Hingorani M
Clin Oncol (R Coll Radiol); 2015 Apr; 27(4):246-7. PubMed ID: 25659888
[No Abstract] [Full Text] [Related]
6. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
7. PCV chemotherapy for recurrent glioblastoma multiforme.
Boiardi A
Neurology; 2001 Jun; 56(12):1782. PubMed ID: 11425963
[No Abstract] [Full Text] [Related]
8. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
Louis E; Keime-Guibert F; Delattre JY; Sanson M
Neurology; 2003 Jan; 60(1):151. PubMed ID: 12525747
[No Abstract] [Full Text] [Related]
9. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
11. Response and control: lessons from oligodendroglioma.
Cairncross JG; Eisenhauer EA
J Clin Oncol; 1995 Sep; 13(9):2475-6. PubMed ID: 7666112
[No Abstract] [Full Text] [Related]
12. Interleukin-2 gene therapy in a patient with glioblastoma.
Sobol RE; Fakhrai H; Shawler D; Gjerset R; Dorigo O; Carson C; Khaleghi T; Koziol J; Shiftan TA; Royston I
Gene Ther; 1995 Mar; 2(2):164-7. PubMed ID: 7719933
[TBL] [Abstract][Full Text] [Related]
13. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
[TBL] [Abstract][Full Text] [Related]
14. [Multimodal treatment of undifferentiated astrocytomas of the cerebrum. Indications for chemotherapy].
Seiler RW
Fortschr Med; 1985 Jun; 103(21):588-90. PubMed ID: 2991092
[No Abstract] [Full Text] [Related]
15. Chemotherapy of primary brain tumors.
Levin VA
Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
Cornetta K; Croop J; Dropcho E; Abonour R; Kieran MW; Kreissman S; Reeves L; Erickson LC; Williams DA
Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
[TBL] [Abstract][Full Text] [Related]
17. PCV chemotherapy for recurrent glioblastoma multiforme.
Kappelle AC; Postma TJ; Taphoorn MJ; Groeneveld GJ; van den Bent MJ; van Groeningen CJ; Zonnenberg BA; Sneeuw KC; Heimans JJ
Neurology; 2001 Jan; 56(1):118-20. PubMed ID: 11148250
[TBL] [Abstract][Full Text] [Related]
18. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.
Tonder M; Eisele G; Weiss T; Hofer S; Seystahl K; Valavanis A; Stupp R; Weller M; Roth P
Acta Oncol; 2014 Oct; 53(10):1436-40. PubMed ID: 24862539
[No Abstract] [Full Text] [Related]
19. [A case of infantile anaplastic astrocytoma treated with surgery and chemotherapy].
Saino M; Kayama T; Sakurada K; Saito S; Sato K
No Shinkei Geka; 1997 Dec; 25(12):1121-6. PubMed ID: 9430149
[TBL] [Abstract][Full Text] [Related]
20. Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
Maipang MVasiknanonte P; Janjindamai SHirunpat S
J Med Assoc Thai; 2000 Dec; 83(12):1525-9. PubMed ID: 11253894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
